Buch, Englisch, 342 Seiten, Format (B × H): 160 mm x 235 mm, Gewicht: 1490 g
Preparation Methods and Research Protocols
Buch, Englisch, 342 Seiten, Format (B × H): 160 mm x 235 mm, Gewicht: 1490 g
Reihe: Methods in Molecular Medicine
ISBN: 978-0-89603-735-9
Verlag: Humana Press
Derek T. O'Hagan and a team of expert vaccinologists and pharmacologists thoroughly describe the preparation, characterization, and evaluation of a wide range of alternative vaccine adjuvants for use in preclinical studies. Each chapter carefully reviews a single adjuvant, and suggests why a specific adjuvant might be preferred for a given antigen, depending on what type of immune response is desired. Alternate adjuvant choices are also presented so that researchers can choose those most efficacious for their specific purpose. Comprehensive and highly practical, Vaccine Adjuvants: Preparation Methods and Research Protocols provides an effective guide to making and using vaccine adjuvants. By closely following directions from the book, today's researchers will be able optimally to induce specific immune responses against different types of antigens and to selectively manipulate the immune response in a favorable way.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
Weitere Infos & Material
An Overview of Adjuvant Use.- Harmful and Beneficial Activities of Immunological Adjuvants.- Freund's Adjuvants.- Aluminum Compounds as Vaccine Adjuvants.- Poly(Lactide-Coglycolide) Microparticles As Vaccine Adjuvants.- Poly(Methyl Methacrylate) Nanoparticles As Vaccine Adjuvants.- Aqueous Formulation of Adjuvant-Active Nonionic Block Copolymers.- Liposomes As Immunological Adjuvants and Vaccine Carriers.- Immunopotentiating Reconstituted Influenza Virosomes (IRIVs).- Cochleates for Induction of Mucosal and Systemic Immune Responses.- Virus-like Particles As Vaccine Adjuvants.- The Adjuvant MF59: A 10-Year Perspective Gary Ott, Ramachandran Radhakrishnan,.- Preparation of the Syntex Adjuvant Formulation (SAF, SAF-m, and SAF-1).- The ISCOM™ Technology.- QS-21 Adjuvant.- MPL® Immunostimulant: Adjuvant Formulations.- Cytokines As Vaccine Adjuvants: The Use of Interleukin-2.- DNA As an Adjuvant.- Transcutaneous Immunization.- Mutant Heat-Labile Entertoxins As Adjuvants for CTL Induction.
